Company Analysis

Altimmune, Inc. (ALT)

Nasdaq: ALT · Pharmaceutical Preparations · Gaithersburg, MD · filing with the SEC since 2005
Grade3.9
◀ Past 3.1● Present 3.5▶ Future 4.8
1 est.

Who owns Altimmune, Inc.

As filed with the SEC
Holders of 5% or more
6
Deep Track Capital, LP holds 9.99% of Common stock, par value $0.0001 per share, as its SCHEDULE 13G filed Apr 30, 2026 says.
Directors and officers
18
report now, of 32 people on the record since 2007. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Deep Track Capital, LP
SCHEDULE 13G · filed Apr 30, 2026 · Common stock, par value $0.0001 per share
9.99%
Chen Yu
SCHEDULE 13G · filed May 1, 2026 · Common Stock, par value $0.0001 per share
9.8%
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 16, 2025 · Common Stock · 8.7% in Feb 5, 2025
7.6%
Viking Global Investors LP
SCHEDULE 13G · filed May 1, 2026 · Common Stock, par value $0.0001 per share
6.7%
RA Capital Management, L.P.
SCHEDULE 13G · filed May 1, 2026 · Common Stock, par value $0.0001 per share
6.5%
State Street Corporation
5.5%
Ameriprise Financial, Inc.
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock · reported falling below 5%, from 7.4% in Feb 14, 2025
under 5%
Tang Capital Management, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common stock, par value $0.0001 per share · reported falling below 5%
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 9.09% in Jan 30, 2026
under 5%
What ALT reports owning in othersstakes of 5% or more, and other ties

4 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 6, 2026.

Insider tradesForm 4
0sales
11purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$400,000bought, in dollars
Open-market trades on Form 4 from Nov 4, 2025 to Nov 4, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
17181920212223242526
2026 runs to Nov 4, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 51 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Durso Jerome BenedictPresident and CEO0$004$200,000
Gill JohnPresident and CEO0$002$100,000
Weaver Gregory LChief Financial Officer0$002$0
Jorkasky Dianedirector0$001$0
Pisano Waynedirector0$001$0
Sohn Catherine A.director0$001$0
SI Assistanton ALT · research, not advice